Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis
Corresponding Author
Thirunavukkarasu Sathish PhD
Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, PhD, Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: speaktosat@gmail.com
Search for more papers by this authorNitin Kapoor MD
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Search for more papers by this authorYingting Cao PhD
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Search for more papers by this authorRobyn J. Tapp PhD
Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Centre for Intelligent Healthcare, Faculty of Health and Life Sciences, Coventry University, Coventry, UK
Search for more papers by this authorPaul Zimmet PhD
Central Clinical School, The Alfred Centre, Monash University, Melbourne, Victoria, Australia
Search for more papers by this authorCorresponding Author
Thirunavukkarasu Sathish PhD
Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, PhD, Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: speaktosat@gmail.com
Search for more papers by this authorNitin Kapoor MD
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Search for more papers by this authorYingting Cao PhD
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Search for more papers by this authorRobyn J. Tapp PhD
Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia
Centre for Intelligent Healthcare, Faculty of Health and Life Sciences, Coventry University, Coventry, UK
Search for more papers by this authorPaul Zimmet PhD
Central Clinical School, The Alfred Centre, Monash University, Melbourne, Victoria, Australia
Search for more papers by this author
Open Research
PEER REVIEW
The peer review history for this article is available at https://publons.com/publon/10.1111/dom.14269.
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study
Supporting Information
| Filename | Description |
|---|---|
| dom14269-sup-0001-Supinfo.docxWord 2007 document , 244 KB | Appendix S1. Supplementary file. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: are there possible cause and effect relationships among them? Diabetes Obes Metab. 2020; 22: 2507-2508.
- 2Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020; 383(8): 789-790.
- 3Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2020. https://doi.org/10.1016/j.diabet.2020.10.002.
- 4Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020; 22(10): 1897-1906.
- 5Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8(6): 546-550.
- 6Vas P, Hopkins D, Feher M, Rubino F, Whyte BM. Diabetes, obesity and COVID-19: a complex interplay. Diabetes Obes Metab. 2020; 22(10): 1892-1896.
- 7Wu L, Girgis CM, Cheung NW. COVID-19 and diabetes: insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol. 2020; 93: 390-393.
- 8Zhang Y, Li H, Zhang J, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single-centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020; 22(8): 1443-1454.
- 9Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8(9): 782-792.
- 10Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020; 8(10): 813-822.
- 11Singh AK, Gillies CL, Singh R, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab. 2020; 22: 1915-1924.
- 12Wu J, Zhang J, Sun X, et al. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes Obes Metab. 2020; 22: 1907-1914.
- 13Sathish T, de Mello GT, Cao Y. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13125.
- 14Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020; 22(10): 1935-1941.
- 15Sathish T, Cao Y, Kapoor N. Newly diagnosed diabetes in COVID-19 patients. Prim Care Diabetes. 2020. https://doi.org/10.1016/j.pcd.2020.08.014.
- 16Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7):e1000100.
- 17Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000; 283(15): 2008-2012.
- 18 American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical Care in diabetes—2020. Diabetes Care. 2020; 43(suppl 1): S14-S31.
- 19Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions, version 6.1 (updated September 2020). 2nd ed. Chichester, UK: John Wiley & Sons; 2019.
10.1002/9781119536604 Google Scholar
- 20 National Institutes of Health. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed October 15, 2020.
- 21DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3): 177-188.
- 22Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950; 21(4): 607-611.
10.1214/aoms/1177729756 Google Scholar
- 23Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11): 1539-1558.
- 24Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343:d4002.
- 25Fadini GP, Morieri ML, Boscari F, et al. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract. 2020; 168:108374.
- 26Lampasona V, Secchi M, Scavini M, et al. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020; 63(12): 2548-2558.
- 27Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care. 2020; 43: 2938–2944.
- 28Smith SM, Boppana A, Traupman JA, et al. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J Med Virol. 2020. https://doi.org/10.1002/jmv.26227.
- 29Wang S, Ma P, Zhang S, et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020; 63(10): 2102-2111.
- 30Yi H, Lu F, Jin X, et al. Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics: a retrospective and multicenter study in China. J Diabetes. 2020; 12: 919-928.
- 31Zhou W, Ye S, Wang W, Li S, Hu Q. Clinical features of COVID-19 patients with diabetes and secondary hyperglycemia. J Diabetes Res. 2020; 2020: 1-9.
- 32Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020; 27(1): 125-136.
- 33Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care. 2006; 29(5): 1140-1149.
- 34Sathish Thirunavukkarasu, Cao Yingting. What is the role of admission HbA1c in managing COVID-19 patients?. Journal of Diabetes. 2020. http://dx.doi.org/10.1111/1753-0407.13140.
